US Patent Issued to Deciphera Pharmaceuticals on March 17 for "GCN2 and perk kinase inhibitors and methods of use thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,249, issued on March 17, was assigned to Deciphera Pharmaceuticals LLC (Waltham, Mass.).

"GCN2 and perk kinase inhibitors and methods of use thereof" was invented by Yu Mi Ahn (Waltham, Mass.), Gada Al-Ani (Waltham, Mass.), Daniel L. Flynn (Waltham, Mass.), Salim Javed (Waltham, Mass.), Patrick Kearney (Waltham, Mass.), Bertrand LeBourdonnec (Waltham, Mass.), Kristen Stoltz (Waltham, Mass.) and Jeffery Zwicker (Waltham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are compounds that are inhibitors of GCN2 kinase or PERK kinase, and methods of treating diseases, including diseases associated with GCN2 kinase or PERK kinase, ...